E. coli-Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine

Emerging influenza viruses pose an extreme global risk to human health, resulting in an urgent need for effective vaccination against influenza infection. Adjuvants are vital components that can improve vaccine efficacy, yet only a few adjuvants have been licensed in human vaccines. Here, we investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Quyen Thi, Kim, Eunjin, Yang, Jihyun, Lee, Chankyu, Ha, Da Hui, Lee, Choon Geun, Lee, Ye Ram, Poo, Haryoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350214/
https://www.ncbi.nlm.nih.gov/pubmed/32560094
http://dx.doi.org/10.3390/vaccines8020306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350214/
https://www.ncbi.nlm.nih.gov/pubmed/32560094
http://dx.doi.org/10.3390/vaccines8020306

Ejemplares similares